You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Prostate cancer

Stockholm3 for prostate cancer screening

  • Medtech innovation briefing
  • Reference number: MIB303
  • Published:  09 August 2022

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Patient organisation comments
  • Expert commentators
  • Development of this briefing

Development of this briefing

This briefing was developed by NICE. The interim process and methods statement for medtech innovation briefings sets out the process NICE uses to select topics, and how the briefings are developed, quality-assured and approved for publication.

ISBN: 978-1-4731-4689-1


Previous page Expert commentators
Back to top